Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of the TD Vaccine System for prevention of travelers' diarrhea caused by ETEC
2008-008726-75Phase 3Completed
- Sponsor
- Intercell AG
- Start
- Mar 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traveler's diarrhea (TD) and Enterotoxigenic Escherichia coli diarrhea comparing TD Vaccine System with Placebo (2 arms). Primary endpoint: Incidence of vaccine preventable outcome. Started Mar 2009; status: completed.
02
Drugs
TD Vaccine System
03
Conditions
traveler's diarrhea (TD)Enterotoxigenic Escherichia coli diarrhea
Beyond the preview
Go deeper on 2008-008726-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008726-75.